• Keerti Bhardwaj
• Arun Sharma
• Sachin Kumar Singh
• Iqbaljit Kaur
• -

Depression is a lifestyle disorder followed by unhealthy thoughts and excessive stress and anxiety and as much as it can cause the damage, it is very difficult to identify specially at earlier stages and its treatment do not just includes medications but therapy as well. The medications that have been approved from FDA are very selective as they affect the brain directly and thus their doses have to be monitored throughout the treatment. While these medications help the patient to cope with depression, some adverse events may also occur at the time of pharmacotherapy. Thus a strict vigilance has to be applied over the action of such drugs on the brain to avoid any undesired event. In this study the pharmacovigilance programme for antidepressant drugs has been observed and their adverse drug reactions were studied.

Depression, antidepressant, medications

"A Study on recent development of Pharmacovigilance programme for Adverse Drug Reaction Monitoring of Antidepressant", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.5, Issue 12, page no.212-216, December 2018, Available :http://www.jetir.org/papers/JETIRDT06026.pdf

"A Study on recent development of Pharmacovigilance programme for Adverse Drug Reaction Monitoring of Antidepressant", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.5, Issue 12, page no. pp212-216, December 2018, Available at : http://www.jetir.org/papers/JETIRDT06026.pdf